Posts tagged “Biotech & Life Science”
2014 is coming to a miserable close for Chapel Hill-based Pozen. After its stock was pummeled 30 percent when Pozen and drug giant Sanofi mutually terminated a $35 million drug deal earlier this month, on Wednesday Pozen disclosed another FDA delay in approval of a new pain killer.
Dr. Stephen DeCherney is the newly named interim chief executive officer at life science services firm Health Decisions. Dr. Michael Rosenberg, the firm's founder and CEO, was killed in a plane crash in Maryland last week.
Red Hat is set to announce its latest quarterly financials on Thursday, and Wall Street won't be surprised if the Hatters deliver better-than-expected results. Or will the Hatters disappoint? A new IBM deal may give Red Hat a boost going forward.
Salix Pharmaceuticals shares rebounded 7 percent Tuesday on news that the Raleigh-based company will launch a plan to reduce drug inventory by the end of 2015. Salix was rocked in November when it acknowledged big inventory problems.
Veteran journalist Jim Shamp sees upside and downside in the recently announced job cuts at GlaxoSmithKline. After all, he notes, cuts in the past as GSK evolved locally from Burrough Wellcome to Glaxo to Glaxo Wellcome and today have produced a harvest of new companies, new ideas, and products. "Yes, a shakeup like GSK's cutback announcement is shattering," he writes. "But these are smart, talented people who will get back on their feet and contribute greatly to North Carolina's life science future."
RTP-based BioCryst Pharmaceuticals is launching a clinical trial of a potential treatment for Ebola with funding support from the U.S. government. Durham-based Chimerix and GSK also are involved in the Ebola battle.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Another North Carolina company is joining the fight in the field against Ebola, but this time not as a provider of a possible vaccine. Winston-Salem based Clinical Ink is being used by a number of firms in the Ebola battle to provide clinical trial data safely through its eData platform.
In today's Bulldog wrapup of technology and life science news: Amazon unveils a "make an offer" service; more new solar sites in North Carolina; Congress told U.S. trails in drones for commercial use; and a Merck breast cancer drug advances.
Even as backers pledged $390 million for Ebola vaccines, Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. It's not the vaccine being tested by GlaxoSmithKline.
Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Wednesday, Dec. 10, 2014 as curated by @WRALTechWire.
Three employees of the Triangle pharmaceutical sciences community were killed in a Monday plane crash in suburban Washington, D.C. Health Decisions CEO Dr. Michael Rosenberg was killed along with David Hartman, a vice president at Nuventra and Chiji Ogbuka, who worked for Health Decisions.
TouchCare, a startup that has developed a mobile app to remotely connect patients and healthcare providers, has landed an equity investment from Mosaic Health Solutions, a subsidiary of Blue Cross and Blue Shield of North Carolina.
Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.
North Carolina is on the forefront of preparation for a potential Ebola crisis as well as helping fight global outbreaks of the dreaded disease, said representatives from the state and national government, the Triangle health care profession, and Triangle private industry at Monday's Ebola Conference at the North Carolina Biotechnology Center.
Dr. Michael Rosenberg, president and CEO of Durham-based Health Decisions, a global clinical research firm, was among six people killed when a plane crashed into a house Monday in Gaithersburg, Md.